“Mitochondrial Dysfunction in Type 2 Diabetes Mellitus: Imeglimin as a Novel Therapeutic Approach”, AJD, vol. 25, no. 1, pp. 7–21, Aug. 2025, doi: 10.59793/0vmn8208.